Neurosurgeons Banned from Research

After treating terminally ill patients with an unauthorized experimental probiotic procedure, two California doctors can no longer participated in human research.

By | July 24, 2012

Flickr, sbluerock

Two neurosurgeons at the University of California, Davis, (UCD) have been suspended from human preclinical research for carrying out experiments on terminal brain cancer patients that were unauthorized by the university and by the US Food and Drug Administration (FDA).

J. Paul Muizelaar, chair of the UCD Health System's Department of Neurosurgery, and assistant professor Rudolph Schrot treated the open brain wounds of three patients with malignant gliomas with a culture of the gram negative Enterobacter aerogenes bacteria in the hopes that the postoperative infection would jumpstart an immune reaction that would fight off the cancer and extend the survival of the patients.

The researchers first considered pursuing the experimental treatment in a terminally ill patient in 2008, but were denied approval by the FDA, which stated that animal studies were necessary "prior to entering into the clinic with your proposed therapy," according to a letter sent to the FDA by a university official in October 2011 detailing the researchers’ actions. Despite this denial, the researchers went ahead with the experimental procedure on three terminally ill patients between October 2010 and March 2011.

The third patient died of sepsis shortly after the procedure, prompting the university’s institutional review board (IRB) to order the researchers to stop their experimental probiotic treatments, , and to launch a 6-month investigation into the matter, The Sacramento Bee reported. Both researchers have since been ordered to stop enrolling new subjects in any research in which they serve as principal or co-principal investigators.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech